<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two Epstein-Barr virus (EBV)-negative <z:hpo ids='HP_0002665'>lymphoma</z:hpo> B-cell lines, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-1 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2, were established from a <z:hpo ids='HP_0002202'>pleural effusion</z:hpo> and a lymph node biopsy of two patients with diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-1 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 showed the characteristics of activated B-cells in B-cell lineage, as did original <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Chromosome analyses revealed that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-1 exhibiting 14q+ marker-positive lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> showed a new subclass of 14q32 translocation resulting from a translocation between chromosomes 14 and 16, which had been masked in a complex translocation involving five chromosomes, and that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 had a 14q+ marker chromosome, the result of an 11;14 translocation [t(11;14)(q13;32)] </plain></SENT>
<SENT sid="3" pm="."><plain>Successful heterotransplantation into athymic <z:mp ids='MP_0003815'>nude</z:mp> mice demonstrated tumorigenicity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-1 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 </plain></SENT>
<SENT sid="4" pm="."><plain>The transplantability and <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> rate of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 were higher and more rapid than those of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-1 </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-1 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-2 appear useful for facilitating therapeutic investigations as well as immunologic and oncogenic studies in B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>